Search - tctmd.com

Displaying 41 - 60 of 355

Sort: Relevancy | Date

Presentation TCT 2024

Medical and Atrial Fibrillation Management for Atrial FMR

Presenter: Gabriel Sayer

October 29, 2024

Presentation TCT 2024

TCT 307: Temporal Trends in Mortality Related to Stroke and Atrial Fibrillation in the United States: A 21-Year Retrospective Analysis of CDC-WONDER Database

Presenter: Hanzala Farooqi

October 29, 2024

Presentation TCT 2024

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021

Presenter: Ankur Singla

October 29, 2024

Presentation TCT 2024

TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Koki Takegawa

October 29, 2024

Presentation TCT 2024

First-in-Human and Early Feasibility Studies with a Dual-Frequency IVUS Imaging System for the Assessment of Plaque Vulnerability Through Lipid and Fibrous Cap Characterization

Presenter: Teng Ma

October 29, 2024

Presentation TCT 2024

TCT 108: Atrial Fibrillation Following Patent Foramen Ovale Closure: A Large Single-Center Institutional Experience

Presenter: Arsh Issany

October 29, 2024

Presentation TCT 2024

TCT 697: Temporal Trends in Mortality in Patients of Atrial Fibrillation and Peripheral Artery Disease Over Past 2 Decades in the US Population

Presenter: Abdul Wali Khan

October 29, 2024

Presentation TCT 2024

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Usman Akbar

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

Top Takeaways From the Afib Guidelines: What’s New for My Practice?

Presenter: Patrick O'Gara

October 28, 2024

Presentation TCT 2024

TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design

Presenter: Tomasz Skowerski

October 28, 2024

Presentation TCT 2024

TCT 511: Peri-Coronary Adipose Tissue a Novel Marker for Post-Ablation Atrial Fibrillation Recurrence: A Comprehensive Systematic Review and Meta-Analysis Revealing Significant Association

Presenter: Sean Paknoosh

October 28, 2024

Presentation TCT 2024

TCT 540: Second-Generation Cryoballoon Ablation vs Contact-Force Sensing Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis

Presenter: Abdul Wali Khan

October 28, 2024

Presentation TCT 2024

TCT 544: Utility of C2HEST Score in Predicting Recurrence of Atrial Fibrillation After Catheter Ablation: A Systematic Review and Meta-Analysis With Reconstructed Time-to-Event Data

Presenter: Saman Al Barznji

October 28, 2024

News Conference News TCT 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

Todd Neale

October 27, 2024

Presentation TCT 2024

TCT 534: Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease

Presenter: Abdullah Al-Abcha

October 27, 2024

Presentation TCT 2024

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Presenter: Wilbert Bor

October 27, 2024

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

Advertisement

Medical and Atrial Fibrillation Management for Atrial FMR

TCT 307: Temporal Trends in Mortality Related to Stroke and Atrial Fibrillation in the United States: A 21-Year Retrospective Analysis of CDC-WONDER Database

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021

TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement

First-in-Human and Early Feasibility Studies with a Dual-Frequency IVUS Imaging System for the Assessment of Plaque Vulnerability Through Lipid and Fibrous Cap Characterization

TCT 108: Atrial Fibrillation Following Patent Foramen Ovale Closure: A Large Single-Center Institutional Experience

TCT 697: Temporal Trends in Mortality in Patients of Atrial Fibrillation and Peripheral Artery Disease Over Past 2 Decades in the US Population

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Top Takeaways From the Afib Guidelines: What’s New for My Practice?

TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design

TCT 511: Peri-Coronary Adipose Tissue a Novel Marker for Post-Ablation Atrial Fibrillation Recurrence: A Comprehensive Systematic Review and Meta-Analysis Revealing Significant Association

TCT 540: Second-Generation Cryoballoon Ablation vs Contact-Force Sensing Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis

TCT 544: Utility of C2HEST Score in Predicting Recurrence of Atrial Fibrillation After Catheter Ablation: A Systematic Review and Meta-Analysis With Reconstructed Time-to-Event Data

LAAO Outcomes Similar Regardless of Operator’s Specialty

TCT 534: Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content